Video

Dr. Baas on Next Steps in the Treatment of Mesothelioma

Author(s):

Paul Baas, MD, professor, Department of Thoracic Oncology, Netherlands Cancer Institute, discusses the future of treatment in mesothelioma.

Paul Baas, MD, professor, Department of Thoracic Oncology, Netherlands Cancer Institute, discusses the future of treatment in mesothelioma.

He maintains that chemotherapy will continue to be extremely relevant in mesothelioma given its efficacy and moderate toxicity. He also highlights that immunotherapy will continue to play a role in this field.

In terms of the differentiation of subtypes of mesothelioma, Baas discusses the identification of groups of patients that may benefit from arginine deprivation treatment, especially in the sarcomatoid type.

Related Videos
Dana Zakalik, MD
David C. Fisher, MD
Kevin Kalinsky, MD, MS
Alberto Montero, MD, MBA, CPHQ
R. Lor Randall, MD, FACS
Daniel E. Haggstrom, MD
Jairam Krishnamurthy, MD, FACP
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Thomas Westbrook, MD, assistant professor, Rush University Medical Center
Kathleen N. Moore, MD, MS